● Recruiting

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

Condition: Schizophrenia · Sponsor: LB Pharmaceuticals Inc.

PhasePhase 3

Planned participants456

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

This is a Phase 3, randomized, double blind, placebo controlled, fixed dose, study designed to evaluate the efficacy, safety, tolerability, and of LB-102 versus placebo for the treatment of adult patients with an acute exacerbation of schizophrenia.

This description comes directly from the study's public registry record.

Talk to the study team

Branislav Mancevski, MD · 212-605-0300 · clinicaltrials@lbpharma.us

Always discuss trial participation with your own doctor first.

Locations (13)

Pillar Clinical Research	Bentonville, Arkansas, United States	Recruiting
Pillar Clinical Research	Little Rock, Arkansas, United States	Recruiting
Woodland International Research Group	Little Rock, Arkansas, United States	Recruiting
ProScience Research Group	Culver City, California, United States	Recruiting
CenExel	Garden Grove, California, United States	Recruiting
Synergy San Diego	Lemon Grove, California, United States	Recruiting
Clinical Innovations, Inc.	Riverside, California, United States	Recruiting
Health Synergy Clinical Research	Boynton Beach, Florida, United States	Recruiting
Innovative Clinical Research	Miami Lakes, Florida, United States	Recruiting
Accelerated Clinical Trial	Snellville, Georgia, United States	Recruiting
Pillar Clinical Research	Chicago, Illinois, United States	Recruiting
Arch Clinical Trials	St Louis, Missouri, United States	Recruiting

+ 1 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07363577